Mylan NV (NASDAQ:MYL)

38.94
Delayed Data
As of Apr 25
 -1.31 / -3.25%
Today’s Change
29.39
Today|||52-Week Range
47.82
-7.97%
Year-to-Date

Today’s Trading

Previous close40.25
Today’s open40.08
Day’s range38.44 - 40.15
Volume6,332,807
Average volume (3 months)5,242,099
Market cap$21.9B
Data as of 4:15pm ET, 04/25/2018

Growth & Valuation

Earnings growth (last year)+41.30%
Earnings growth (this year)+18.28%
Earnings growth (next 5 years)+6.30%
Revenue growth (last year)+7.06%
P/E ratio30.0
Price/Sales1.91
Price/Book1.67

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...+0.40+0.49%
PRGOPerrigo Company PLC-2.67-3.32%
JAZZJazz Pharmaceuticals...+0.16+0.10%
ALNYAlnylam Pharmaceutic...-0.40-0.42%
Data as of 4:02pm ET, 04/25/2018

Financials

Next reporting dateMay 3, 2018
EPS forecast (this quarter)$1.10
Annual revenue (last year)$11.9B
Annual profit (last year)$696.0M
Net profit margin5.85%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Heather M. Bresch
President &
Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts